For patients receiving Abilify Maintena (once monthly dosing), administer ABILIFY ASIMTUFII 960 mg (once every 2 month dosing) in place of the next scheduled injection of the Abilify Maintena. The first ABILIFY ASIMTUFII injection may be administered in place of the second, or later injection of Abilify Maintena.
Receiving Abilify Maintena. For patients receiving Abilify Maintena (once monthly dosing), administer Abilify Asimtufii 960 mg once q2month in place of next scheduled injection of Abilify Maintena; Administer first Abilify Asimtufii injection in place of second, or later injection of Abilify Maintena
For more details about the dosages of Abilify Maintena and Abilify Asimtufii, as well as how they differ, see the Abilify Maintena and Abilify Asimtufii dosing section below. Abilify
ABILIFY MAINTENA comes in the following dosage forms: Powder for Usual adult dose: After the first ABILIFY MAINTENA injection, the usual dose
Initiating ABILIFY MAINTENA (aripiprazole). The recommended starting and maintenance dose is 400 mg once monthly for ABILIFY MAINTENA. If there are adverse
acute phase of schizophrenia, ABILIFY MAINTENA is withdrawn, the ABILIFY MAINTENA dosage may need to be increased to the previous dose.
For more details about the dosages of Abilify Maintena and Abilify Asimtufii, as well as how they differ, see the Abilify Maintena and Abilify Asimtufii dosing section below. Abilify
and Abilify Maintena . Abilify Maintena shares the same indications as Abilify Asimtufii. Aristada is approved for the treatment of schizophrenia in adults. The efficacy of Abilify Asimtufii (once every 2-month dosing) was based on adequate and well-controlled studies of Abilify Maintena (once monthly dosing).
limit of normal In the Abilify Maintena group, for 96.4% of patients, there was no difference between the starting dose and ending dose of Abilify Maintena (
Comments